Published in Blood Weekly, December 25th, 2003
Results of the Calcium Acetate Renagel Evaluation (CARE study), an eight-week randomized, double-blinded, controlled study that compared the efficacy of calcium acetate and sevelamer were presented at the 36th Annual American Society of Nephrology's Meeting in San Diego, CA in November 2003.
Controlling elevated phosphorus levels...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.